Adjuvants - a strategic component in modern vaccine

  • Adjuvants should be evaluated early in the vaccine development for optimum vaccine performance
  • Choosing the right adjuvants early in the research

Dr Karin Lovgren Bengtsson at World Vaccine Congress Lyon 2012

Dr Karin Lovgren Bengtsson

CSO at Isconova since 2000 University degree in biochemistry, doctoral degree in virology, senior lecturer at the Swedish University of Agricultural Sciences and holder of seven patents Has worked...

more..
Thomas Phillipson at World Vaccine Congress Lyon 2012

Thomas Phillipson

Director, Business Development at Isconova since 2010. Masters Degree in Pharmaceutical Sciences and MBA from Henley Business School Extensive experience in sales, marketing and strategy from the...

more..

Speakers - read more about

Share this

Comments

comments require javascript
Sponsors
Gold Sponsor
GE Healthcare at World Vaccine Congress Lyon 2012
Gold Sponsor
Millipore at World Vaccine Congress Lyon 2012
Gold Sponsor
Labcorp Clinical Trials at World Vaccine Congress Lyon 2012
Silver Sponsor
Medicago Inc at World Vaccine Congress Lyon 2012
Associate Sponsor
Crucell Holland B.V. at World Vaccine Congress Lyon 2012
Associate Sponsor
Bird-C at World Vaccine Congress Lyon 2012
Showcase Sponsor
Aurigon Life Science GmbH at World Vaccine Congress Lyon 2012
Showcase Sponsor
Immune Targeting Systems (ITS) Ltd at World Vaccine Congress Lyon 2012